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Nucleic Acid Therapeutics 
•  DNA Therapeutics and Vaccines 
•  Replace malfunctioning / missing gene (e.g., Hemophilia) 
•  In situ production of antigen to generate provide 
immunization against viral infections (e.g., Ebola, Zika, Flu)
•  RNA Therapeutics
•  Small-interfering RNA, microRNA, antisense RNA 
•  Inhibit / silence specific genes 
•  Applications in cancer, diabetes, cardiovascular disease 
•  Thousands of clinical trials completed or 
currently underway
Glybera – 1st approved product 
Lipoprotein Lipase 
Deficiency (LPLD) 
•  Very rare disorder – one per 
million 
•  Glybera à dramatic improvement 
in lipoprotein metabolism
•  1st gene therapy product 
•  Approved in Europe (not in U.S.) in 2013
Glybera – 1st approved product 
•  Cost is for treating a single patient!
Glybera – 1st approved product 
•  Cost is for treating a single patient!
•  Total mass of DNA ≈ 0.1 µg à $10 trillion / g
•  Significant challenges in purification, with 
exciting potential opportunities for membrane 
technology
DNA Transmission vs Flux 
3.0 kbp plasmid DNA 
RDNA ≈ 73 nm 
Rpore ≈ 9 nm (300 kD MWCO) 
10 mM Tris-EDTA buffer 
§  DNA transmission 
negligible at low 
filtrate flux
§  DNA transmission 
increases to >60% 
at high flux, even 
though DNA is 
nearly 10x the size 
of the membrane 
pores
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DNA Transmission – Stirring 
3.0 kbp plasmid DNA 
RDNA ≈ 73 nm 
Rpore ≈ 9 nm  
10 mM Tris-EDTA buffer 
§  DNA transmission 
independent of 
stirring speed at any 
given flux (even in 
absence of stirring)
§  Increase in 
transmission at high 
flux not due to 
concentration 
polarization
Effect of DNA Size on Transmission 
















•  Elongational flow into pore stretches DNA 





Elongation of DNA 
Significant Transmission 
DNA Elongation 
Video provided by Ron Larson, University of Michigan
Membrane Fouling 
§  Significant fouling 
seen during DNA UF 
with transmission 
dropping to zero at 
long filtration times
§  Rate of fouling 
increases significantly 
with increasing DNA 
concentration
§  Impractical for large 
scale DNA purification
DNA “Trapping” 
•  Large DNA 
molecules become 
trapped at entrance 
to narrow pores due 
to incomplete 
elongation leading to 
membrane fouling





Pre-stretching in UF 
•  Approach – use 
membranes with flow 
from substructure to skin
•  Passage through 
membrane substructure 
should “pre-stretch” the 
DNA, minimizing DNA 
trapping in pores in UF 
skin layer
Filtration
Pre-stretching - Fouling 
•  Use of asymmetric 
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Supercoiled DNA, Jv = 60 µm/s




membrane formed by 
placing MF on top of 
UF membrane 
•  Optimal pore size for 
pre-stretching appears 
to be around 0.1 µm 
•  New opportunity for 
membrane design 
DNA Isoform Purification 
•  DNA exists in different topological isoforms
•  Supercoiled isoform is desired for therapeutic 
applications à open-circular and linear 
isoforms are considered process impurities 




DNA Isoform Purification 
•  DNA exists in different topological isoforms
•  Hypothesis – Differences in elongational 
flexibility of different isoforms may provide 





Sieving of DNA Isoforms 
Linear & Open-circular forms generated by
enzymatic digestion of Supercoiled
300 kD membrane 




•  Much higher 
transmission of 
linear DNA -> most 
easily elongated 
•  Transmission of 
supercoiled DNA 
intermediate 
•  Nearly complete 
retention of open-
circular DNA due 
to low flexibility 
DNA Isoform Purification by UF 
36 LMH 97 LMH 
104 L/m2/h 17 kbp DNA 
Permeate 
17 kbp DNA, 300 kD membrane, 10 mM Tris-EDTA buffer   
Supercoiled DNA Purification 











•  “Pre-stretching” dramatically increases selectivity 




•  RNA transmission 
increases with 
increasing filtrate 
flux, similar to 
behavior seen with 
DNA 
•  No effect of stirring, 
suggesting that 
transmission is 
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with 70 bp (≈23 
kDa) RNA 
 






•  Nucleic acid transmission through UF 
membranes due to flow-induced elongation à 
different isoform flexibility leads to separation 
•  Pre-stretching DNA in large pore region 
significantly reduces fouling while increasing 
selectivity à opportunity for developing 
membranes with novel pore morphology 
•  RNA ultrafiltration depends on RNA structure  
•  Exciting opportunities for development of 
membrane processes for nucleic acid purification 
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